Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Therapeutic Choices for Psoriasis and Mental Health

J Dermatolog Treat; ePub 2018 May 14; Salame, et al

Therapeutic choices for psoriasis impact mental health outcomes, according to a recent study, which determined that biologic therapy is associated with reductions in psychological distress and depression as compared to oral therapy in the US adult moderate-to-severe psoriasis population. Researchers performed a nationwide, cross-sectional study comparing 2,303,534 (weighted) adults with moderate-to-severe psoriasis on biologic vs oral therapies and their associated mental health outcomes using the 2003-2015 Medical Expenditure Panel Survey (MEPS). Mental health outcomes were measured with the Kessler 6 (K6), a validated measure of psychological distress, and Patient Health Questionnaire 2 (PHQ2), a screening tool for depression. They found:

  • The mean K6 score for residents on biologic therapies was significantly lower than that of residents on oral therapies (2.72 vs 3.70).
  • The mean PHQ2 score for residents on biologic therapies was also significantly lower than that of residents on oral therapies (0.540 vs 0.890).
  • Based on adjusted multivariable linear regression models, biologic therapy was associated with significant reductions in K6 and PHQ2 scores compared to oral therapy.
Citation:

Salame N, Ehsani-Chimeh N, Armstrong AW. Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: A population-based study. [Published online ahead of print May 14, 2018]. J Dermatolog Treat. doi:10.1080/09546634.2018.1476654

This Week's Must Reads

Dermatologist-Delivered Intervention Is Effective, JAMA Dermatology; ePub 2018 Aug 8; Mallett, et al

HRQOL in Patients with Cutaneous T-Cell Lymphoma, Int J Dermatol; ePub 2018 Aug 3; Holahan, Farah, et al

Disparities Seen in Access to Injectable Biologics , J Dermatolog Treat; ePub 2018 Aug 4; Feng, et al

Psoriasis Not Associated with Higher Dementia Risk, J Am Acad Dermatol; ePub 2018 Aug 6; Pezzolo, et al

Discerning Merkel Cell Carcinoma from Other Tumors, Am J Dermapathol; ePub 2018 Jul 24; Bandino, et al

Must Reads in Psoriasis

Psoriasis Not Associated with Higher Dementia Risk, J Am Acad Dermatol; ePub 2018 Aug 6; Pezzolo, et al

Psoriasis, Nonalcoholic Fatty Liver Disease Linked, J Clin Asthet Dermatol; 2018 Jun 1; Awosika, et al

Dietary Recommendations for Adults with Psoriasis, JAMA Dermatology; ePub 2018 Jun 20; Ford, et al

20% of Patients with Psoriasis Found to Have PsA, J Am Acad Dermatol; ePub 2018 Jun 18; Alinaghi, et al

Citizen Pscientist: Important New Research Tool, Dermatol Ther (Heidelb); ePub 2018 Jun 6; Sanchez, et al